WINNIPEG, Manitoba, March 01, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that it has completed its final services milestone under an agreement with Ontario based Micro Cultivation partner, F1NE Cannabis Cultivation LTD. (“F1”). F1 is an arm’s length third party in which the Company has no ownership control or interest.
As one of Delta 9’s Micro Cultivation partners, F1 entered into a Strategic Cooperation Agreement (“SCA”) with the company whereby Delta 9 provides services relating to the cannabis production, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, marketing services to develop the F1 brand and other services supporting the acquisition of the Health Canada license.
On February 19, 2021, F1 confirmed it had reached its final milestone under the SCA and has been granted its cannabis micro cultivation licenses from Health Canada (the “Health Canada License”).
“We are delighted that F1NE Cannabis Cultivation has received a Health Canada Licence for our proprietary and turn-key Grow Pod systems,” said John Arbuthnot, Founder and CEO of Delta 9. “Our turn key platform for Grow Pods and services continues to prove one of the best options for cannabis industry entrepreneurs seeking licensing and support services.”
The Company's cannabis production methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which are based on retrofitted 40-foot shipping containers. The turn key smart growing platforms are developed using precision hardware and software grow applications for the indoor cannabis cultivation marketplace. Delta 9 offers vertical growing units, integrated grow racks, and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and automated fertigation and watering systems.
F1’s facility has been designed using this turn key and state of the art Grow Pod system. Once cultivation is harvested, Delta 9 plans to purchase the premium quality cannabis products from F1 for distribution through the Company's established distribution network, and through Delta 9's branded retail stores. Delta 9 has now successfully licensed over 100 Grow Pods in third party facilities across Canada.
“F1NE Cannabis Cultivation is a privately owned boutique cannabis cultivator based in the Niagara Region of Ontario, close to dozens of wineries along the wine route to Niagara on the lake and the Horse Shoe Falls,” said Poncho Canna, President and CEO of F1NE Cannabis Cultivation. “Our goal is to produce the F1NEST quality cannabis product by bringing the legacy-market craft to a legal-market product.”
F1 has developed a state-of-the-art micro cultivation facility on a one-and-a-half-acre parcel of land situated on Lake Ontario and beside some of the worlds best wine producers. F1 has applied and is expecting to receive a farm gate licence to sell their products directly to consumers traveling along the wine routes to Niagara on the lake and as part of the wine tours in the area.
The facility includes some of the latest technology surrounding climate control and grow room automation. F1 expects this facility to be the first step in a more significant growth strategy, as it makes plans to double its production by growing a smaller plant that will leave room for two levels of cannabis production per Grow Pod. There are also plans in place to build an outdoor garden centre for customers to buy pots, grow mediums, lights and other items to grow like the pros.
The well-rounded F1 Team has a strong entrepreneurial background, with an executive team that has many years experience of growing cannabis. The F1 Team is committed and passionate about growing premium craft cannabis and looks forward to rooting a leading craft cannabis company in Ontario.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "VRNDF". For more information, please visit www.delta9.ca.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future.
Forward looking statements in this news release include statements relating to: (i) F1's proposed micro cultivation operations; (ii) Delta 9's intention to sell F1's premium cannabis products; and (iii) Delta 9's development of micro cultivation services. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including F1’s cannabis production not being as anticipated, as well as all risk factors set forth in the annual information form of Delta 9 dated March 19, 2020 which has been filed on SEDAR.
No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.